510916525 | PUO | 07122247 | | 5156600 | 4/19/2003 12:00:00 AM | s/p ureteral stent | | DIS | Admission Date: 4/19/2003 Report Status:
Discharge Date: 2/16/2003
****** DISCHARGE ORDERS ******
FULVIO , ANGILA P 456-02-11-5
Orl Au , Hawaii 18977 Room: Son Chulinownettesalt Seatza Mont
Service: URO
DISCHARGE PATIENT ON: 10/19/03 AT 09:00 AM
CONTINGENT UPON Not Applicable
WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES
Attending: MANKOSKI , ROSSIE , M.D.
CODE STATUS:
Full code
DISPOSITION: Home
DISCHARGE MEDICATIONS:
ALLOPURINOL 100 MG PO QD
ELAVIL ( AMITRIPTYLINE HCL ) 25 MG PO QHS
Override Notice: Override added on 2/26/03 by RICHINS , MARLANA YUKI , M.D.
on order for LEVOFLOXACIN PO 250 MG QD ( ref # 95302735 )
POTENTIALLY SERIOUS INTERACTION: AMITRIPTYLINE HCL &amp;
LEVOFLOXACIN Reason for override: will monitor
Previous override information:
Override added on 4/30/03 by RICHINS , MARLANA YUKI , M.D.
on order for LEVOFLOXACIN PO ( ref # 01736061 )
POTENTIALLY SERIOUS INTERACTION: AMITRIPTYLINE HCL &amp;
LEVOFLOXACIN Reason for override: will monitor
ATENOLOL 100 MG PO QD Starting Today ( 1/13 )
COLCHICINE 0.6 MG PO BID
COLACE ( DOCUSATE SODIUM ) 100 MG PO BID
LASIX ( FUROSEMIDE ) 40 MG PO BID Starting Today ( 1/13 )
GLIPIZIDE 5 MG PO QD
ATROVENT INHALER ( IPRATROPIUM INHALER ) 2 PUFF INH QID
NIFEREX-150 150 MG PO BID
Instructions: separate from Levoflox dose by two hours
Alert overridden: Override added on 2/26/03 by
TAAL , DARLA TOSHIA , M.D.
POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN &amp;
POLYSACCHARIDE IRON COMPLEX Reason for override:
will separate doses by 2 hours Previous Alert overridden
Override added on 2/26/03 by TAAL , DARLA TOSHIA , M.D.
POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN &amp;
POLYSACCHARIDE IRON COMPLEX Reason for override: ok
PERCOCET 1 TAB PO Q6H PRN Pain
SIMVASTATIN 80 MG PO QHS
Food/Drug Interaction Instruction
Avoid grapefruit unless MD instructs otherwise.
ISOSORBIDE MONONITRATE 60 MG PO QD
Food/Drug Interaction Instruction
Give on an empty stomach ( give 1hr before or 2hr after
food ) Number of Doses Required ( approximate ): 9
ACARBOSE 25 MG PO TID
Number of Doses Required ( approximate ): 5
LEVOFLOXACIN 250 MG PO QD
Food/Drug Interaction Instruction
Administer iron products a minimum of 2 hours before or
after a levofloxacin or ciprofloxacin dose dose
If on tube feeds , please cycle ( hold 1 hr before to 2 hr
after ) Take 2 hours before or 2 hours after dairy products.
Override Notice: Override added on 2/26/03 by
TAAL , DARLA TOSHIA , M.D.
on order for NIFEREX-150 PO 150 MG BID ( ref # 36242341 )
POTENTIALLY SERIOUS INTERACTION: LEVOFLOXACIN &amp;
POLYSACCHARIDE IRON COMPLEX Reason for override:
will separate doses by 2 hours
Previous override information:
Override added on 2/26/03 by RICHINS , MARLANA YUKI , M.D.
POTENTIALLY SERIOUS INTERACTION: AMITRIPTYLINE HCL &amp;
LEVOFLOXACIN Reason for override: will monitor
Previous Alert overridden
Override added on 4/30/03 by RICHINS , MARLANA YUKI , M.D.
POTENTIALLY SERIOUS INTERACTION: AMITRIPTYLINE HCL &amp;
LEVOFLOXACIN Reason for override: will monitor
COMBIVENT ( IPRATROPIUM AND ALBUTEROL SULFATE )
2 PUFF INH QID
FENOFIBRATE 54 MG PO QD
Number of Doses Required ( approximate ): 5
PROTONIX ( PANTOPRAZOLE ) 40 MG PO QD
URISED 2 TAB PO QID PRN Pain
DIET: No Restrictions
ACTIVITY: Walking as tolerated
FOLLOW UP APPOINTMENT( S ):
Dr. Lorean Kadow , call to scheudle appointment 2-3 weeks ,
Dr. Derham , call to schedule appointment as directed ,
Dr. Spillett call to schedule appointment next week ,
ALLERGY: Cephalosporins
ADMIT DIAGNOSIS:
Forniceal Rupture
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission )
s/p ureteral stent
OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay
lad stent 2/14 dm ( diabetes mellitus ) obesity
( obesity ) hyperchol ( elevated cholesterol ) gout
( gout ) emphysema ( chronic obstructive pulmonary disease ) renal
insufficiency ( chronic renal dysfunction ) sick sinus syndrome ( sick
sinus syndrome ) pacemaker ( pacemaker )
OPERATIONS AND PROCEDURES:
Placement right ureteral stent by Dr. Lorean Kadow
OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. )
None.
BRIEF RESUME OF HOSPITAL COURSE:
69M with known AAA present three days from ureteroscopy at TH
complicated by forniceal rupture with flank and groin pain. To OR on
HD#2 for ureteral stent placement. Procedure without complications.
Patient tolerated well. Stent was noted to drain bloody fluid during
procedure. Post-op patient had mild flank discomfort consistent with
stent placement. POD#1 patient has eposide of hypertension to 90/45
systolic with mild postural dizziness. Sx and signs resoved with Po
fluids and holding one dose atenolol. At time of discharge on POD#2
patient was comfortable , tolerating PO and without dizziness or
hypotension.
ADDITIONAL COMMENTS: You may experience soem flank and groin discomfort from the stent. Take
pain medications as needed. If you esperience severe abdominal or back
pain come to the emergency department. Call Urology clinic for
questions or concerns related to the stent. Schedule follow-up with Dr.
Bucknor regarding treatment of your aneurysm.
DISCHARGE CONDITION: Stable
TO DO/PLAN:
No dictated summary
ENTERED BY: KNOWER , ANGELIA ROSLYN , M.D. ( ZK82 ) 10/19/03 @ 09
****** END OF DISCHARGE ORDERS ******